Patents by Inventor Roberta L. Rogowski

Roberta L. Rogowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Low-Dose Doxepin For Treatment Of Sleep Disorders In Elderly Patients
    Publication number: 20220151975
    Abstract: Methods of treating sleep disorders, particularly certain aspects of insomnia, in elderly patients (65 years and older) by administering initial daily dosages of doxepin of 1-3 mg. These ultra-low initial dosages are more effective in elderly versus non-elderly patients in decreasing wake time during sleep, latency to persistent sleep and wake time after sleep, and are particularly efficacious in treating those conditions in the last hour of an 8-hour sleep cycle. Also, the dosages described herein are safe for elderly individuals.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Applicants: Currax Pharmaceuticals LLC, ProCom One, Inc.
    Inventors: Roberta L. Rogowski, Susan Ellen Dube, Philip Jochelson, Neil B. Kavey
  • Low-Dose Doxepin Formulations And Methods Of Making And Using The Same
    Publication number: 20220110908
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: August 23, 2021
    Publication date: April 14, 2022
    Applicant: Currax Pharmaceuticals LLC
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Low-dose doxepin for treatment of sleep disorders in elderly patients
    Patent number: 11234954
    Abstract: Methods of treating sleep disorders, particularly certain aspects of insomnia, in elderly patients (65 years and older) by administering initial daily dosages of doxepin of 1-3 mg. These ultra-low initial dosages are more effective in elderly versus non-elderly patients in decreasing wake time during sleep, latency to persistent sleep and wake time after sleep, and are particularly efficacious in treating those conditions in the last hour of an 8-hour sleep cycle. Also, the dosages described herein are safe for elderly individuals.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: February 1, 2022
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Roberta L. Rogowski, Susan Ellen Dube, Philip Jochelson, Neil Barton Kavey
  • Methods Of Improving The Pharmacokinetics Of Doxepin
    Publication number: 20210393567
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Application
    Filed: September 6, 2021
    Publication date: December 23, 2021
    Applicant: Currax Pharmaceuticals LLC
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Methods of improving the pharmacokinetics of doxepin
    Patent number: 11110074
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: September 7, 2021
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Low-dose doxepin formulations and methods of making and using the same
    Patent number: 11096920
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: August 24, 2021
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
    Publication number: 20200345680
    Abstract: Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).
    Type: Application
    Filed: May 18, 2020
    Publication date: November 5, 2020
    Applicants: Currax Pharmaceuticals LLC, ProCom One, Inc.
    Inventors: Roberta L. Rogowski, Susan E. Dubé, Philip Jochelson, Neil B. Kavey
  • Methods Of Improving The Pharmacokinetics Of Doxepin
    Publication number: 20200276151
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Application
    Filed: May 18, 2020
    Publication date: September 3, 2020
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Low-Dose Doxepin Formulations And Methods Of Making And Using The Same
    Publication number: 20200170991
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: February 3, 2020
    Publication date: June 4, 2020
    Applicant: Currax Pharmaceuticals LLC
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Methods of using low-dose doxepin for the improvement of sleep
    Patent number: 10653662
    Abstract: Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: May 19, 2020
    Assignees: Currax Pharmaceuticals LLC, ProCom One, Inc.
    Inventors: Roberta L. Rogowski, Susan E. Dubé, Philip Jochelson, Neil B. Kavey
  • Methods of improving the pharmacokinetics of doxepin
    Patent number: 10653660
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: May 19, 2020
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Low-dose doxepin formulations and methods of making and using the same
    Patent number: 10548871
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: February 4, 2020
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Low-Dose Doxepin Formulations And Methods Of Making And Using The Same
    Publication number: 20200000763
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: March 5, 2018
    Publication date: January 2, 2020
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
    Publication number: 20190216766
    Abstract: Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).
    Type: Application
    Filed: March 25, 2019
    Publication date: July 18, 2019
    Inventors: Roberta L. Rogowski, Susan E. Dubé, Philip Jochelson, Neil B. Kavey
  • Methods of using low-dose doxepin for the improvement of sleep
    Patent number: 10238620
    Abstract: Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: March 26, 2019
    Assignees: Pernix Sleep, Inc., ProCom One, Inc.
    Inventors: Roberta L. Rogowski, Susan E. Dubé, Philip Jochelson, Neil B. Kavey
  • Low-Dose Doxepin Formulations And Methods Of Making And Using The Same
    Publication number: 20180256533
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: March 5, 2018
    Publication date: September 13, 2018
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
    Publication number: 20180125809
    Abstract: Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).
    Type: Application
    Filed: January 8, 2018
    Publication date: May 10, 2018
    Inventors: Roberta L. Rogowski, Susan E. Dubé, Philip Jochelson, Neil B. Kavey
  • Low-dose doxepin formulations and methods of making and using the same
    Patent number: 9907780
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: March 6, 2018
    Assignee: Pernix Sleep, Inc.
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Methods of using low-dose doxepin for the improvement of sleep
    Patent number: 9861607
    Abstract: Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: January 9, 2018
    Assignees: Procom One, Inc., Pernix Sleep, Inc.
    Inventors: Roberta L. Rogowski, Susan E. Dubé, Philip Jochelson, Neil B. Kavey
  • LOW-DOSE DOXEPIN FORMULATIONS AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20170172973
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: December 30, 2016
    Publication date: June 22, 2017
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox